TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05324514

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Split-thickness skin grafting
Description: Harvesting for split-thickness skin grafting will be performed at the specified donor site using a pneumatically powered dermatome with a setting of 10 /1000th inch and meshed 2:1.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High density microscopic skin tissue column grafting
Description: MSTC harvest will be conducted using the ART system (Medline Industries) in accordance with the manufacturer's instructions and distributed at high density (300-360 columns/50cm2).

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low density microscopic skin tissue column grafting
Description: MSTC harvest will be conducted using the ART system (Medline Industries) in accordance with the manufacturer's instructions and distributed at low density (150-180 columns/50cm2).
Study: NCT06161389

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Partially inflated mask
Description: Manikin ventilation with a partially inflated mask

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fully inflated mask
Description: Manikin ventilation with a fully inflated mask
Study: NCT05585450

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: BL32 and BL33 will be inserted by needles of 0.30×75mm size at an angle of 45°, inward and downward, to the depth of 60-70mm. BL35 will be inserted by needles of 0.30×75mm size, slightly outward and upward, to the depth of 60-70mm. SP6 will be inserted by needles of 0.30×40mm to the depth of 25-30mm. The needles will be lifted, thrust, and twisted evenly three times after insertion to induce the sensation of deqi.~The electronic acupuncture apparatus (Yingdi KWD 808I electro pulse acupuncture therapeutic apparatus, Changzhou Yingdi Electronic Medical Device Co., Ltd) will be connected to the four pairs of needles transversally, with a continuous wave of 5 Hertz (Hz) and an electric current of 2-6.5 milliampere (mA) for BL32, BL33 and BL35, and 0.5 mA-2mA for SP6.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham electroacupuncture
Description: The four pairs of acupoints will be inserted by needles of 0.30×25mm or 0.30×40mm size to a depth of 2-3mm till the needles can stand still. No manipulations will be conducted, and the sensation of deqi will not be induced.~The electronic acupuncture apparatus (Yingdi KWD 808I electro pulse acupuncture therapeutic apparatus, Changzhou Yingdi Electronic Medical Device Co., Ltd) will be connected to the four pairs of needles transversally, with a continuous wave of 5 Hz and a minimal electric current (ideally at a degree which participant can just percept). In about 30 seconds, the electric current will be turned down, leaving the indicator light and ticking sound on.
Study: NCT02217202

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aquacel Ag dressing
Description: Participants will have their knee arthroplasty wound dressed using the Aquacel Ag dressing instead of the standard Aquacel dressing.
Study: NCT06165393

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Slow-release CHO-AA
Description: Slow-release CHO-AA, alginate encapsulated

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Slow-release CHO
Description: Slow-release CHO, alginate encapsulated

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: CHO
Description: Carbohydrate-only, control
Study: NCT05417919

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Solution-oriented Nursing in Violence Against Women (SONVAW)
Description: The Personal Information Form was filled in by the students themselves before the program. İSKEBE was filled before, after the program and at the follow-up 3 months later. 3 days were determined for the program for the students in the experimental group, and the program was applied for 60 minutes a day for 6 weeks, allowing the students to participate in the program on a suitable day
Study: NCT05902806

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Upgraded tube feed
Description: Total duration of study: 4 weeks; 1 week on current tube feed followed by 2 weeks on upgraded tube feed comparable in energy density and fiber content as their current tube feed. The tube feeding regimen is similar to pre study feeding regimen. There will then be a one week follow up period.
Study: NCT06225713

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: focused power ultrasound mediated inferior perirenal adipose tissue modification
Description: This novel focused power ultrasound is an externally delivered, completely noninvasive focused therapeutic ultrasound device. It is capable of focusing the resulting ultrasound beam to a small cigar-shaped volume and monitoring the temperature of the target area, which leads to the rapid elevation of the peri-renal adipose tissue temperature and the destruction of target tissue eventually.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham-control group
Description: Participants will receive the sham control therapy (including peri-renal fat ultrasonic measurement and localization, focused ultrasound treatment parameters setting), however, without initiating the focused ultrasound equipment.
Study: NCT06193668

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: High-fat overnutrition
Description: Overnutrition: 40% higher lipid consumption per day than required

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Normocaloric macronutrient-balanced nutrition
Description: Normocaloric, macronutrient-balanced nutrition:~Calories requirement for weight maintenance \[(kcal/d) 55% carbohydrates, 15% proteins, 30% fat\]
Study: NCT06403969

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Applied Behavior Analysis
Description: Applied Behavior Analysis focusing on nocturnal awakenings. It starts with identification of target behaviors and goals. A functional analysis is conducted to analyze the underlying function of a behavior in connection to the problem. A treatment plan is formulated, including strategies to achieve the goals, and methods to evaluate. Families receive education sleep hygiene. Adaptations focus on antecedents and consequences, with an emphasis on positive reinforcement of favorable behaviors. Various components of Cognitive Behavioral Therapy may be applicable. These include changes in sleep environment, stimulus control, bedtime routines with visual support and prompting. Sleep restriction and bedtime fading are included. Modified extinction techniques with parental presence can be applied, gradually phasing out parental immediate presence. The intervention continues until goals are achieved or for a maximum of 8 sessions (each lasting up to 60 minutes) spread over 8 weeks.
Study: NCT05002075

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: m-health cardiac rehabilitation
Description: Participants randomized to m-Health cardiac rehabilitation will receive a 24-week home-based exercise program delivered via a previously validated, commercially available smartphone platform called Movn (Moving Analytics, California). This app includes a patient-facing iOS and Android compatible smartphone app and an integrated hospital-facing online dashboard for remote monitoring and care coordination by a trained coach
Study: NCT05529797

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Veovita-VR
Description: Veovita-VR is a VR intervention with positive emotional stimuli and positive behavioral activation designed to reduce depressive symptoms in people with at least moderate depressive symptoms. In the VR session, the participants stay in a beautiful environment (island, sandy beach, beautiful scenery). They can engage in activities that are perceived as positive (climbing, treasure hunting, listening to music, building sandcastles). The session has a length of approx. 30 minutes. Participants are free to continue to engage with any treatment they require during the duration of the study.
Study: NCT05300763

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: senofilcon A prototype
Description: Test

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dailies Total 1
Description: Control
Study: NCT05987410

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nordic Walking (NW)
Description: The experimental group will carry out NW sessions three times a week for 12 weeks, supervised by a NW instructor and under the control of a cardiologist. The duration of each NW session will initially be 90 minutes: 10 minutes of warm-up, 60 of NW, and 15 minutes of cool-down. The intensity of the course will be gradually increased each week, starting at 70 to 85% of the heart rate (HR) reserve. It will also receive indications relating to a balanced diet plan which proposes a moderate (300-400 KCal) daily caloric restriction concerning the usual caloric expenditure, estimated based on initial body composition measurements.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Rehabilitation (SR)
Description: The second group will follow a standard rehabilitation program with an initial cardiological prescription and supervised by physiotherapists, carried out 5 days a week with sessions lasting 40 minutes, including 5 minutes of warm-up up), 30 min of aerobic physical activity on a conveyor belt or cycle ergometer and 5 minutes of cooling down (cool down). The intensity of your aerobic activity will gradually increase each week, starting at 70 to 85% of HR reserve. It will also receive indications relating to a balanced diet plan which proposes a moderate (300-400 KCal) daily caloric restriction concerning the usual caloric expenditure, estimated based on initial body composition measurements.

Intervention type: OTHER
Group type: OTHER
Intervention: Cardiological Counselling (CC)
Description: The third group of participants will receive cardiological counselling with indications of unsupervised aerobic physical activity. The group will also receive indications relating to a balanced diet plan which proposes a moderate (300-400 KCal) daily caloric restriction concerning the usual caloric expenditure, estimated based on initial body composition measurements.
Study: NCT05843396

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neonatal Massage
Description: caregivers providing therapeutic touch techniques on their neonate
Study: NCT05766046

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: early lung cancer detection
Description: standard treatment for early lung cancer detection with LDCT at one or two years interval

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: early lung cancer detection
Description: standard treatment for early lung cancer detection with LDCT at one or two years interval

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood test
Description: blood analysis for microRNA and other biomarkers detection

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood test
Description: blood analysis for microRNA and other biomarkers detection
Study: NCT03585738

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inositol + Folic acid
Description: Daily oral supplementation before spontaneous conception until delivery:~Myo-Inositol: 1100 mg D-chiro-inositol: 27.6 mg Folic acid: 400 mcg

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Folic acid
Description: Daily oral supplementation before spontaneous conception until delivery:~Folic acid: 400 mcg
Study: NCT04670471

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Remimazolam is an intravenous anaesthetic and sedative drug. Remimazolam exhibits its anaesthetic effects via the benzodiazepine binding site at the GABAA receptor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Remimazolam is an intravenous anaesthetic and sedative drug. Remimazolam exhibits its anaesthetic effects via the benzodiazepine binding site at the GABAA receptor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Remimazolam is an intravenous anaesthetic and sedative drug. Remimazolam exhibits its anaesthetic effects via the benzodiazepine binding site at the GABAA receptor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Remimazolam is an intravenous anaesthetic and sedative drug. Remimazolam exhibits its anaesthetic effects via the benzodiazepine binding site at the GABAA receptor.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: Remifentanil is a commonly used opioid in anaesthetic practice. It is a potent and fast-acting analgesic.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: Remifentanil is a commonly used opioid in anaesthetic practice. It is a potent and fast-acting analgesic.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: Remifentanil is a commonly used opioid in anaesthetic practice. It is a potent and fast-acting analgesic.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remifentanil
Description: Remifentanil is a commonly used opioid in anaesthetic practice. It is a potent and fast-acting analgesic.
Study: NCT05726708

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: E-Learning
Description: On line modules of coaching for parents

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: E-Learning
Description: On line modules of coaching for parents
Study: NCT05330299

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COMPASS
Description: Participants will be treated with an online CBT program that is specifically tailored to illness-related distress in the context of long-term conditions. It consists of 11 online modules and is therapist-supported.
Study: NCT05391490

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: KCAT19 T cells
Description: Allogeneic, cord unit derived KCAT19 T cells
Study: NCT03468140

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eculizumab
Description: Eculizumab will be given at a dose of 1200mg diluted in 0.9% sodium chloride (NaCl) to 5mg/mL for a total volume of 240 mL administered by IV infusion over 25-45 minutes in the anhepatic-phase during the transplant procedure, and a second dose of 900mg diluted in 0.9% NaCl to 5mg/mL for a total volume of 180 mL administered by IV infusion over 25-45 minutes will be given 24 hours following the first dose.

Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: Historical control arm
Study: NCT06164002

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: change in restoration material and margin design.
Description: comparing two different materials and two different designs. use artificial intelligence in the prediction of follow up results

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: change in restoration material and margin design.
Description: comparing two different materials and two different designs. use artificial intelligence in the prediction of follow up results

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: change in restoration material and margin design.
Description: comparing two different materials and two different designs. use artificial intelligence in the prediction of follow up results

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: change in restoration material and margin design.
Description: comparing two different materials and two different designs. use artificial intelligence in the prediction of follow up results
Study: NCT03879161

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vu-Path™
Description: Femoral arterial access in eligible participants will be performed using the Vu-Path™.
Study: NCT04502082

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ET140203 autologous T cell product
Description: Autologous T cells transduced with lentivirus encoding an ET140203 expression construct
Study: NCT05694416

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide Plus Cisplatin
Description: Etoposide Plus Cisplatin ivdrip d1-5
Study: NCT06202820

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CV Care Program
Description: Comprised of two, in-clinic, counseling sessions with oncology nurse practitioner or physician assistant for education on cardiovascular disease (CVD) and cardiovascular risk factors as well as recommendations for management.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CV Care Program
Description: Comprised of two, in-clinic, counseling sessions with oncology nurse practitioner or physician assistant for education on cardiovascular disease (CVD) and cardiovascular risk factors as well as recommendations for management.
Study: NCT05169008

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Description: Intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalation (Ad5-nCoV-IH)
Description: Nebulized inhalation through the mouth
Study: NCT05019911

Intervention type: DEVICE
Intervention: Polysomnography
Description: In the cross-sectional part, the group of patients with COPD alone and the group of patients with COPD combined with sleep apnea hypopnea syndrome will be monitored by traditional sleep monitoring equipment (polysomnography) for vital signs in order to diagnose COPD combined with sleep apnea hypopnea syndrome.

Intervention type: DEVICE
Intervention: Polysomnography
Description: In the cross-sectional part, the group of patients with COPD alone and the group of patients with COPD combined with sleep apnea hypopnea syndrome will be monitored by traditional sleep monitoring equipment (polysomnography) for vital signs in order to diagnose COPD combined with sleep apnea hypopnea syndrome.

Intervention type: DEVICE
Intervention: Millimeter wave radar equipment
Description: In the cross-sectional part, the group of patients with COPD alone and the group of patients with COPD combined with sleep apnea hypopnea syndrome will be monitored by millimeter wave radar equipment for vital signs in order to diagnose COPD combined with sleep apnea hypopnea syndrome. In the cohort part, both groups of patients will be continuously monitored by millimeter wave radar equipment for vital signs for months in order to establish a model to predict acute exacerbations of COPD combined with sleep apnea hypopnea syndrome.

Intervention type: DEVICE
Intervention: Millimeter wave radar equipment
Description: In the cross-sectional part, the group of patients with COPD alone and the group of patients with COPD combined with sleep apnea hypopnea syndrome will be monitored by millimeter wave radar equipment for vital signs in order to diagnose COPD combined with sleep apnea hypopnea syndrome. In the cohort part, both groups of patients will be continuously monitored by millimeter wave radar equipment for vital signs for months in order to establish a model to predict acute exacerbations of COPD combined with sleep apnea hypopnea syndrome.
Study: NCT05908019

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Web-based health care program
Description: According to the participants' feedback and recommends, we will modify this program to make it more suitable.~In the second and third years, we will conduct a parallel-group, double blind, and block randomization, experimental design study to examine the effectiveness of the Pulmonary Hypertension Web-Based Care Program on the improvements of patients' social support, self-care ability, active tolerance, symptom distress, depression, anxiety and quality of life in patients with PAH.
Study: NCT05244252

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexmeditomidine and bupivacaine
Description: Transversus abdominis plane block will be given bilaterally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: bupivacaine
Study: NCT05147259

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR011408 injection
Description: Drug: HR011408 injection (formulation A), administered subcutaneously. Drug: HR011408 injection (formulation B), administered subcutaneously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR011408 injection
Description: Drug: HR011408 injection (formulation A), administered subcutaneously. Drug: HR011408 injection (formulation B), administered subcutaneously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR011408 injection
Description: Drug: HR011408 injection (formulation A), administered subcutaneously. Drug: HR011408 injection (formulation B), administered subcutaneously.
Study: NCT06313918

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity training (HIT)
Description: Please see information already included in the arm descriptions.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High intensity training (HIT)
Description: Please see information already included in the arm descriptions.
Study: NCT04995952

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gross motor training
Description: Gross motor training activity (1 hour session, 3 times a week for 3 months). Pre ad post assessments will be taken. The Gross motor training activity will include: sit to stand, step-ups and walking. The sit to stand will be performed for 20 minutes involving 20 repetitions. We will progress from high seat sit to stand to low seat sit to stand. The step up will progress initially from a bench having low height to high height and then to stepping of stairs for 20 minutes involving 30 repetitions. The walking will occur from 3m walk and then increasing the distance

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trunk targeted training
Description: Trunk targeted training (1hour session, 3 times a week for 3 months). Pre and Post assessment will be evaluated. The trunk targeted training will include: weight supported treadmill walk, specific trunk exercises with vibration therapy and reaching forward to the limits of stability.~Specific trunk exercises will involve stride sitting to standing, sitting on a roll and moving the roll in diagonal and forward backward directions along with giving vibrational therapy on wobble board, side sitting. This activity will be performed for 30 minutes with 30 repetitions. Reaching forward to the limits of stability exercises will be performed. Asking the children to hold objects from right hand while reaching for an object on left side and vice versa. This will be performed for 20 minutes having 20 repetitions.
Study: NCT04336878

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Habits in Pregnancy and Beyond
Description: Habit-based intervention to support the development of 10 healthy dietary and activity behaviours for pregnant women with overweight or obesity.